Development of a physiologic-based pharmacokinetic model for estimating sulfamethazine concentrations in swine and application to prediction of violative residues in edible tissues
Authors:
- Ronald E. BaynesRBRonald E. Baynes
- Arthur L. CraigmillACArthur L. Craigmill
- Jim E. RiviereJRJim E. Riviere
- 1 October 2005
- journal article
- research article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 66 (10) , 1686-1693
Abstract
Objective—To develop a flow-limited, physiologicbased pharmacokinetic model for use in estimating concentrations of sulfamethazine after IV administration to swine. Sample Population—4 published studies provided physiologic values for organ weights, blood flows, clearance, and tissue-to-blood partition coefficients, and 3 published studies provided data on plasma and other tissue compartments for model validation. Procedure—For the parent compound, the model included compartments for blood, adipose, muscle, liver, and kidney tissue with an extra compartment representing the remaining carcass. Compartments for the N-acetyl metabolite included the liver and the remaining body. The model was created and optimized by use of computer software. Sensitivity analysis was completed to evaluate the importance of each constant on the whole model. The model was validated and used to estimate a withhold interval after an IV injection at a dose of 50 mg/kg. The withhold interval was compared to the interval estimated by the Food Animal Residue Avoidance Databank (FARAD). Results—Specific tissue correlations for plasma, adipose, muscle, kidney, and liver tissue compartments were 0.93, 0.86, 0.99, 0.94, and 0.98, respectively. The model typically overpredicted concentrations at early time points but had excellent accuracy at later time points. The withhold interval estimated by use of the model was 120 hours, compared with 100 hours estimated by FARAD. Conclusions and Clinical Relevance—Use of this model enabled accurate prediction of sulfamethazine pharmacokinetics in swine and has applications for food safety and prediction of drug residues in edible tissues. (Am J Vet Res 2005;66:1686–1693)Keywords
This publication has 20 references indexed in Scilit:
- Application of a Physiologically Based Pharmacokinetic Model for Reference Dose and Reference Concentration Estimation for AcetoneJournal of Toxicology and Environmental Health, Part A, 2003
- Free drug fraction vs. free drug concentration: a matter of frequent confusionJournal of Veterinary Pharmacology and Therapeutics, 2002
- Extrapolated Withdrawal-Interval Estimator (EWE) Algorithm: A Quantitative Approach to Establishing Extralabel Withdrawal TimesRegulatory Toxicology and Pharmacology, 2002
- INVESTIGATION OF THE POTENTIAL IMPACT OF BENCHMARK DOSE AND PHARMACOKINETIC MODELING IN NONCANCER RISK ASSESSMENTJournal of Toxicology and Environmental Health, 1997
- Deacetylation as a determinant of sulphonamide pharmacokinetics in pigsVeterinary Quarterly, 1997
- The biotransformation of sulfadimethoxine, sulfadimidine, sulfamethoxazole, trimethoprim and aditoprim by primary cultures of pig hepatocytesJournal of Veterinary Pharmacology and Therapeutics, 1997
- Application of an enzyme immunoassay for the determination of sulphamethazine (sulphadimidine) residues in swine urine and plasma and their use as predictors of the level in edible tissueFood Additives & Contaminants, 1996
- Pharmacokinetics and renal clearance of sulphadimidine, sulphamerazine and sulphadiazine and their N4‐acetyl and hydroxy metabolites in pigsVeterinary Quarterly, 1989
- Pharmacokinetics, renal clearance, tissue distribution, and residue aspects of sulphadimidine and its N4‐acetyl metabolite in pigsVeterinary Quarterly, 1986
- Physiological Model for Distribution of Sulfathiazole in SwineJournal of Pharmaceutical Sciences, 1984